Tumor‐stroma interactions differentially alter drug sensitivity based on the origin of stromal cells

Due to tumor heterogeneity, most believe that effective treatments should be tailored to the features of an individual tumor or tumor subclass. It is still unclear, however, what information should be considered for optimal disease stratification, and most prior work focuses on tumor genomics. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Landry, Benjamin D, Leete, Thomas, Richards, Ryan, Cruz‐Gordillo, Peter, Schwartz, Hannah R, Honeywell, Megan E, Ren, Gary, Schwartz, Alyssa D, Peyton, Shelly R, Lee, Michael J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078165/
https://www.ncbi.nlm.nih.gov/pubmed/30082272
http://dx.doi.org/10.15252/msb.20188322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078165/
https://www.ncbi.nlm.nih.gov/pubmed/30082272
http://dx.doi.org/10.15252/msb.20188322

Ejemplares similares